Lipid CME
LECTURECME

Best of Lipid Forum® 2017 — Beyond Statin Therapy: Getting the Low Down on LDL Management

Author(s)/Faculty: James A. Underberg, FACPM, FACP, FASH, FNLA; Michael J. Blaha, MD, MPH; Michael Miller, MD, FACC, FAHA; Marc S. Sabatine, MD, MPH
Release Date: 3/9/2018Expiration Date: 3/8/2019
Credit Type: CMENumber of Credits: 1.25
Content Type: LectureProvider:
Nearly one-third of adults in the United States have an elevated low-density lipoprotein cholesterol (LDL-C), which is a major risk factor for cardiovascular disease and stroke. Frontline intervention for these patients is diet and exercise, as well as statin therapy. Although this approach is beneficial to many patients, nearly 30% of patients fail to meet their treatment goals on statin therapy and many cannot tolerate intensification of therapy with higher dosing. For these patients and for those with severely elevated LDL-C levels, physicians must consider the use of non-statin therapies to achieve treatment goals. Clinical data regarding the long-term safety and efficacy of non-statin LDL-C–lowering agents continue to emerge, resulting in frequent updates to clinical guidelines. This educational initiative will address the most recent clinical updates regarding the use of non-statin therapies, as well as provide expert advice regarding their utilization, to improve the management of patients with elevated LDL-C and reduce cardiovascular risk.